source
- Abivax’s ulcerative colitis pill shows high remission rates but cancer cases spark safety worriesAbivax reported that its experimental oral therapy for ulcerative colitis achieved strong efficacy in a Phase 3 maintenance trial involving 580 patients who had previously responded in shorter stud…
- ASCO Highlights Barriers to Cancer Care and New Treatments Amid Memorable Pancreatic Cancer Study OvationThe annual ASCO meeting featured extensive discussion of the obstacles patients face in accessing cancer care and showcased a range of emerging therapies. STAT compiled a quick‑take newsletter tha…